Our Services
Medical Information
Helpful Resources
Published on: 7/15/2026
What are overactive bladder (OAB) medications with the least side effects?
Mirabegron, a beta-3 agonist, is widely regarded by doctors as an effective treatment for overactive bladder (OAB). Unlike older anticholinergic medications, mirabegron typically causes fewer side effects such as dry mouth, constipation, and cognitive issues, making it a preferred option for many patients—especially older adults or those sensitive to traditional OAB drugs.
If you're experiencing symptoms like sudden urges to urinate, frequent bathroom trips, or leakage, it's important to understand what's driving them before choosing a treatment path. A free, instant, online symptom check can help you identify potential causes, clarify your next steps, and prepare for a more productive conversation with your doctor—all in just a few minutes.
Reviewed for medical accuracy: 07/15/2026
Important Next Steps
Not seeing your question? No worries.
Submit your own QuestionExplanation
Overactive bladder (OAB) is treated with different medicines. Older drugs, often called anticholinergics, work by calming the bladder but can sometimes cause unwanted side effects like dry mouth, constipation, and blurred vision.
In recent years, many doctors prefer using mirabegron. Mirabegron is a beta-3 agonist that relaxes the bladder in a different way. Because it does not block the same nerves as anticholinergics, patients often have fewer side effects. Studies and guidelines suggest that mirabegron is one of the medications for OAB with a better tolerability profile.
Of course, each person may respond differently, so what works best can vary. If you're experiencing bladder symptoms and want to better understand what might be causing them, try our free AI symptom checker to help identify potential issues. It is important to talk with your doctor about your symptoms and any concerns about side effects. Your doctor can help tailor a treatment plan that suits you while balancing benefits with the possibility of side effects.
(References)
Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, Radomski SB, Stothers L, Wagg A, Lond F. CUA guideline on adult overactive bladder. Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9. Erratum in: Can Urol Assoc J. 2017 May;11(5):E250. doi: 10.5489/cuaj.4722. Erratum in: Can Urol Assoc J. 2017 Jul;11(7):E323. doi: 10.5489/cuaj.4775. PMID: 28503229; PMCID: PMC5426936.
Milsom I, Wagg A, Oelke M, Chapple C. Which drugs are best for overactive bladder? From patients' expectations to physicians' decisions. Int J Clin Pract. 2021 Apr;75(4):e13870. doi: 10.1111/ijcp.13870. Epub 2020 Dec 11. PMID: 33251651; PMCID: PMC8047881.
Sze C, Drangsholt S, Stoddard MD, Singh Z, Sansone S, Bhojani N, Zorn K, Elterman D, Chughtai B. Adverse Events for Overactive Bladder Medications From a Public Federal Database. Female Pelvic Med Reconstr Surg. 2022 Jul 1;28(7):429-435. doi: 10.1097/SPV.0000000000001190. Epub 2022 May 17. PMID: 35536677.
Tell your friends about us.
We would love to help them too.
For First Time Users
What is Ubie’s Doctor’s Note?
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.